 |
Regulatory Inprocess Changes
Process Validation and Out of Specification Findings
|
|
 |
Patent Term Extension
Sample Format For Submission
|
|
 |
GMP Regulations
21 GFR Parts 210 and 211
|
|
 |
Human Drug GMP Notes
June 2000, March 2000,
Sept 2000
|
|
 |
Policies and Procedures
Submission of Electronic Case Reports |
|
 |
International Agreement Documents
(available from the FDA Office of Regulatory Affairs)
Belarus:
- MOU with Belarus regarding information exchange for drugs and biologics. (Mar 27/96)
Canada:
Germany:
- MOU on Good Laboratory Practices (Dec 23/88)
Italy:
- MOU on Good Laboratory Practices (Dec 19/88)
Japan:
- Note Verbale with Japan on Good Laboratory Practices (Apr 15/83)
Russia:
- MOU with Russia on drugs and biological products (Feb 2/97)
United Kingdom:
Canada and Mexico:
- Memorandum of Cooperation with Canada and Mexico on cooperation in the scientific and regulatory fields (Oct 30/95)
- Submission of Electronic Case Reports
- Information Exchange
FDA International Contacts:
|
|
 |
Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements; Proposed Rule
Thursday February 6, 1997 -- Part IV
Department of Health and Human Services
Food and Drug Administration
|
|